ManTech International Corp
Change company Symbol lookup
Select an option...
MANT ManTech International Corp
AMPE Ampio Pharmaceuticals Inc
MA Mastercard Inc
RJF Raymond James Financial Inc
PACW PacWest Bancorp
MAPS WM Technology Inc
AR Antero Resources Corp
PAYX Paychex Inc
AEHL Antelope Enterprise Holdings Ltd
NOV Nov Inc
Go

Industrials : Professional Services | Small Cap Value
Company profile

ManTech International Corporation is a provider of technology solutions and services for the United States intelligence community, defence and federal civilian agencies. The Company is engaged in offering a spectrum cyber, data collection and analytics, enterprise information technology (IT) and systems engineering and software application development solutions that supports national and homeland security. It provides services and solutions that support missions of national priority, such as global cyber operations, military operational readiness, information technology (IT) and digital modernization, and national security threat intelligence and analytics. It focuses on cyber network operations, defence, analytics, hardening and resilience, security orchestration, automation and response, range and training, and risk management and compliance. It also provides model-based systems engineering, predictive analytics, data/computational science, and cloud engineering solutions.

Closing Price
$73.52
Day's Change
0.32 (0.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
73.83
Day's Low
72.30
Volume
(Heavy Day)
Volume:
186,988

10-day average volume:
140,882
186,988

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 1, 2021 - SPPI

3:06 pm ET October 28, 2021 (Newsfile) Print

New York, New York--(Newsfile Corp. - October 28, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, Inc. ("Spectrum") (NASDAQ: SPPI) between December 27, 2018 and August 5, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of Nevada. To get more information go to:

https://www.zlk.com/pslra-1/spectrum-pharmaceuticals-inc-loss-submission-form?prid=20751&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7091/101198_609705_logo.jpg

Spectrum Pharmaceuticals, Inc. NEWS - SPPI NEWS

CASE DETAILS: According to the filed complaint: (i) the manufacturing facility for ROLONTIS, an investigational granulocyte-colony stimulating factor analog, maintained deficient controls and/or procedures; (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration would approve the ROLONTIS biologics license application ("BLA") in its current form; (iii) Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT THIS MEANS TO SHAREHOLDERS: If you suffered a loss in Spectrum, you have until November 1, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased Spectrum securities between December 27, 2018 and August 5, 2021, you may be entitled to compensation without payment of any out-of-pocket costs or fees.

PROTECT YOUR FINANCIAL INTERESTS: Complete this brief submission form https://www.zlk.com/pslra-1/spectrum-pharmaceuticals-inc-loss-submission-form?prid=20751&wire=5 or call 212-363-7500 to discuss the case with Joseph E. Levi, Esq.

WHY LEVI & KORSINSKY: Levi & Korsinsky have a proven track record of winning cases worth hundreds of millions of dollars for shareholders over a 20-year period. We represent and fight for shareholders who have been wronged by corporations.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington, D.C. The Firm's Founding Partners, Joseph Levi and Eduard Korsinsky, have been representing shareholders and institutional clients for almost 20 years and have achieved remarkable results for clients in the U.S. and internationally. The firm, with more than 80 employees, is committed to fostering, cultivating and preserving a culture of diversity, equity and inclusion for employees and those that we represent. Our attorneys have extensive expertise representing investors in securities litigation with a track record of recovering hundreds of millions of dollars in cases. Levi & Korsinsky was ranked in Institutional Shareholder Services' ("ISS") SCAS Top 50 Report for 7 years in a row as a top securities litigation firm in the United States. The SCAS Top 50 Report identifies the top plaintiffs' securities law firms in the country, and year after year, ISS has recognized Levi & Korsinsky as a leading firm in the area of securities class action litigation.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/101198

comtex tracking

COMTEX_395975037/2523/2021-10-28T15:06:57

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.